Avicanna To Hold Full Year 2024 Earnings Conference Call
TORONTO, March 18, 2025 (GLOBE NEWSWIRE) -- Avicanna Inc. (' Avicanna ' or ' Company ') (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based products, invites interested parties to participate in a conference call with Aras Azadian, Chief Executive Officer, and also Phil Cardella, Chief Financial Officer, where Mr. Azadian and Mr. Cardella will discuss the Company's Full Year 2024 financial results.
The Company will file Full Year 2024 financial results after the close of market on March 31, 2025 and will host an earnings call at 8:30 am ET on April 1, 2025. Interested parties may join the earnings call by clicking below:
Please use Passcode 240829.
About Avicanna:
Avicanna is a commercial-stage international biopharmaceutical company focused on the advancement and commercialization of cannabinoid-based products and formulations for the global medical and pharmaceutical market segments. Avicanna has an established scientific platform including R&D and clinical development leading to the commercialization of more than thirty proprietary, evidence-based finished products and supporting four commercial-stage business pillars.
Medical Cannabis formulary (RHO Phyto™): The formulary offers a diverse range of proprietary products including oral, sublingual, topical, and transdermal deliveries with varying ratios of cannabinoids, supported by ongoing patient and medical community education. RHO Phyto is an established brand in Canada currently available nationwide across several channels and expanding into new international markets.
Medical cannabis care platform (MyMedi.ca): MyMedi.ca is a medical cannabis care platform formed with the aim to better serve medical cannabis patients' needs and enhance the medical cannabis patients' journey. MyMedi.ca is operated by Northern Green Canada Inc. and features a diverse portfolio of products and bilingual pharmacist-led patient support programs. MyMedi.ca also provides specialty services to distinct patient groups such as veterans and collaborates with public and private payers for adjudication and reimbursement. MyMedi.ca provides educational resources to the medical community to facilitate the incorporation of medical cannabis into health care regimens.
Pharmaceutical pipeline: Leveraging Avicanna's scientific platform, vertical integration, and real-world evidence, Avicanna has developed a pipeline of proprietary, indication-specific cannabinoid-based candidates that are in various stages of clinical development. These cannabinoid-based candidates aim to address unmet needs in the areas of dermatology, chronic pain, and various neurological disorders.
Active pharmaceutical ingredients (Aureus Santa Marta™): Active pharmaceutical ingredients supplied by the Company's majority owned subsidiary Santa Marta Golden Hemp SAS ('SMGH') is a commercial-stage business dedicated to providing various forms of high-quality CBD, THC and CBG to the Company's international partners for use in the development and production of food, cosmetics, medical, and pharmaceutical products. SMGH also forms part of the Company's supply chain and is a source of reliable input products for its consumer retail, medical cannabis, and pharmaceutical products globally.
SOURCE Avicanna Inc.
Stay Connected
For more information about Avicanna, visit our website or contact Ivana Maric by email at info@avicanna.com.
Cautionary Note Regarding Forward-Looking Information and Statements
This news release contains 'forward-looking information' within the meaning of applicable securities laws. Forward-looking information contained in this news release may be identified by the use of words such as, 'may', 'would', 'could', 'will', 'likely', 'expect', 'anticipate', 'believe', 'intend', 'plan', 'forecast', 'project', 'estimate', 'outlook' and other similar expressions. Forward-looking information contained in this news release includes, without limitation, statements related to the Offering, the use of proceeds of the Offering, the receipt of all approvals of the Toronto Stock Exchange in connection with the Offering, statements with respect to the Company's future business operations, the opinions or beliefs of management and future business goals. Although the Company believes that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because the Company can give no assurance that they will prove to be correct. Actual results and developments may differ materially from those contemplated by these statements. Forward-looking information is subject to a variety of risks and uncertainties that could cause actual events or results to differ materially from those projected in the forward-looking information. Such risks and uncertainties include, but are not limited to current and future market conditions, including the market price of the common shares of the Company, and the risk factors set out in the Company's annual information form dated April 1, 2024, filed with the Canadian securities regulators and available under the Company's profile on SEDAR+ at www.sedarplus.ca. The statements in this news release are made as of the date of this release. The Company disclaims any intent or obligation to update any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Market Online
2 days ago
- The Market Online
Weekend sampler: 3 micro-cap stocks to watch
With the TSX up by 5.7 per cent over the past month, just shy of its all-time-high, driven by a rebound in the price of oil, and the S&P 500 following suit, up by 6.8 per cent, emboldened by strong U.S. jobs data, investors are growing increasingly immune to Trump's tariff bluster. They're realizing that he's but one among many short-term headwinds, along with wars, recessions and a diversity of cultural conflicts, which stocks have proven more than capable of overcoming on their way to delivering attractive long-term returns. While financial media has a vested interest in making you worry about next quarter's earnings or the effects of a single central bank interest rate decision, fundamentals and value will always prevail in the end. This means it's always the right time to consider stocks with the potential to reward patient investors, grounded in the understanding that short-term volatility is the price of long-term gains. To this end, as you kick your feet up and kick off the well-deserved weekend, here are three fundamentally attractive micro-cap stocks for your perusing pleasure, each of them worth a deep dive towards a potential investment thanks to positive earnings per share year-over-year and evidence for keeping the profits flowing into the future. BQE Water Our first micro-cap stock pick, BQE Water (TSXV:BQE), market cap C$65.93 million, last trading at C$51 per share, specializes in water treatment and management for the mining, smelting and refining markets. Although the stock has added 363 per cent since 2020, supported by more than 100 per cent revenue and net income growth – including a strong Q1 2025 – it's down by 20 per cent year-over-year, likely discounting numerous projects near completion expected to drive growth through year-end. Olympia Financial Group Our second micro-cap stock pick, Olympia Financial (TSX:OLY), market cap C$266.57 million, last trading at C$110.78, administers self-directed registered plan accounts, corporate trusts, transfer agency services, currency exchange, global payments, private health plans and information technology services in the Canadian market. The company more than doubled revenue from C$48.62 million in 2020 to C$102.92 million in 2024, while tripling net income over the period from C$7.99 million to C$23.92 million, respectively, following this up with a steady Q1 2025 marked by a growing client base. Under the care of a long-tenured management team with 34-per-cent insider ownership, Olympia is in the midst of a multi-pronged growth plan (slide 25) to expand its established position in private markets, granting investors a data-driven thesis for meaningful gains, despite the stock adding 184 per cent since 2020. ADF Group Our final micro-cap stock to watch, ADF Group (TSX:DRX), market cap C$188.29 million, last trading at C$6.70, is a top designer and engineer of steel structures for the North American non-residential infrastructure sector. The company's over 65-year track record includes infrastructure projects spanning airports, stadiums, factories and office towers, with a current capacity to manufacture 125,000 tons of structural steel per year. If we look at ADF's past five years, we see expanding market share justified by accelerating profits. This includes revenue growth from C$172.59 million in fiscal 2021 to C$339.63 million in fiscal 2025, proven efficient by net income growth from C$6.87 million to C$56.79 million over the period. Tariff fears have since hit the stock with steep losses to the tune of 60 per cent year-over-year – most recently hampered by an increase in U.S. steel tariffs which Canada may reciprocate – with new contracts slowing and lower expected revenue and margins through the fiscal year ending January 2026. That said, the stock remains up by more than 500 per cent since 2020 – including the year-over-year loss – thanks to management's stellar operational track record. While tariff uncertainty is peaking at the moment, the high likelihood of a reasonable resolution between Canada and the U.S., given that they're commercially tied-at-the-hip, puts the profitable ADF on a path to retracing recent losses, fueled by an over C$400 million backlog as of January 2025. Should you invest in BQE Water, Olympia Financial and ADF Group today? The stocks we've discussed in this article only deserve a place in your portfolio if they match up with your financial goals, risk tolerance and time horizon. Take care to paint a clear picture of your personal financial circumstances and conduct thorough due diligence on a prospective company before putting any money to work. Join the discussion: Find out what everybody's saying about these micro-cap stocks to watch on the BQE Water Inc., Olympia Financial Group Inc. and ADF Group Inc. Bullboards and check out the rest of Stockhouse's stock forums and message boards. The material provided in this article is for information only and should not be treated as investment advice. For full disclaimer information, please click here.
Cision Canada
2 days ago
- Cision Canada
Minsud Announces Option Grant
TORONTO, June 6, 2025 /CNW/ - Minsud Resources Corp. (TSXV: MSR) (" Minsud" or the " Company") is pleased to announce that it has granted options to purchase an aggregate of 600,000 common shares of the Company (the " Stock Options") to certain directors of the Company. The Stock Options are exercisable at a price of $0.60 per share for a period of five years from the date of issuance. As of the date hereof, a total of 16,494,852 common shares of the Company are reserved for issuance under the Company's stock option plan and, after this new grant, 13,876,000 options will be outstanding. About Minsud Resources Corp. Minsud is a mineral exploration company focused on exploring its flagship Chita Valley Cu-Mo-Au-Ag-Pb-Zn Project, in the Province of San Juan, Argentina. The Company's shares are listed on the TSX-V under the trading symbol "MSR", and on the OTCQX under the symbol "MDSQF". Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. SOURCE Minsud Resources Corp.
Cision Canada
2 days ago
- Cision Canada
Minco Silver Announces Grant of Stock Options
VANCOUVER, BC, June 6, 2025 /CNW/ - Minco Silver Corporation (the "Company") announces that its Board of Directors has approved the grant of an aggregate of 2,900,000 incentive stock options to directors, officers, consultants and employees of the Company, pursuant to the Company's Long-Term Incentive Plan. The stock options are exercisable at a price of $0.21 per common share, being the closing price of the Company's shares on the Toronto Stock Exchange on June 3, 2025. The options will expire five years from the date of grant and are subject to vesting over a period of 18 months, in accordance with the terms of the Company's Long-Term Incentive Plan. The Long-Term Incentive Plan was approved by the Company's shareholders at its Annual General Meeting held on June 28, 2024, and subsequently approved by the Toronto Stock Exchange on July 15, 2024. About Minco Silver Corporation Minco Silver Corporation (TSX: MSV / OTCQX: MISVF / WKN: A0ESX5) is a Canadian-based company focused on the acquisition, exploration, and development of high-grade silver properties. The Company remains committed to building shareholder value through strategic investments and disciplined project evaluation. SOURCE Minco Silver Corporation
